IP Library Granted Patent US 7,485,448
Granted Patent B2
US 7,485,448 · App. 11/519,775 · Granted Feb 3, 2009

Serum-free medium for producing retroviruses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,485,448
App. No.
11/519,775
Granted
Feb 3, 2009
Kind
B2
Abstract

A method for obtaining a virus vector free of a serum, and a serum-free medium for cultivation of a virus producer cell which can be used for the method are provided. By cultivating a virus producer cell using a serum-free medium containing serum albumin, it is possible to cultivate the cell in a state equivalent to that in a serum-containing medium to produce a virus vector at a sufficient titer. The virus vector prepared from the virus producer cell cultivated in the medium exhibits gene transfer efficiency comparable to that of a conventional vector. The medium is useful for gene therapy and studies thereof.

Claims (11)

1. A serum-free medium used for cultivation of a virus producer cell, comprising:

(a) human serum albumin at a concentration of 0.05 to 1% by weight;

(b) calcium at a concentration of 2.70 to 4.51 mmol/L; and

(c) a virus producer cell.

2. The medium according to claim 1 , further comprising interleukin-2.

3. The medium according to claim 2 , wherein interleukin-2 is at a concentration of 10 to 1000 JRU/ml.

4. The medium according to claim 1 , further comprising epidermal growth factor.

5. The medium according to claim 1 , wherein the virus producer cell is a recombinant retrovirus vector producer cell.

6. A method for producing a substance of interest, the method comprising cultivating a cell capable of producing a substance of interest in the medium defined by claim 1 to produce said substance of interest.

7. The method according to claim 6 , wherein the cultivation is initiated by inoculating a stock of the cell capable of producing the substance of interest into said medium.

8. The method according to claim 6 , wherein the substance of interest is a recombinant retrovirus vector.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2006
From: YOSHIOKA, HIROFUMI; KATAYAMA, YASUSHI; TOMURA, DAISUKE; FUNAKOSHI, MASAO; MATSUMOTO, KAZUYA; MINENO, JUNICHI; TAKESAKO, KAZUTOH; KATO, IKUNOSHIN
To: TAKARA BIO INC.
Reel/Frame 018680/0269 →